![Michael Chang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Chang
Plus aucun poste en cours
Profil
Michael N.
Chang is the founder of Optimer Pharmaceuticals LLC (1998), Pharmanex, Inc. (1994), and OBI Pharma, Inc. (2002).
At Optimer Pharmaceuticals LLC, he held the title of Director from 1998 to 2013.
At Pharmanex, Inc., he held the title of Chief Science Officer, SVP-Research & Development.
At OBI Pharma, Inc., he held the title of Chairman & Spokesman.
Dr. Chang's former jobs include Director-Drug Development Division at Rhone-Poulenc Rorer, Inc., Deputy Director-Pharmaceutical Chemistry at Merck Sharp & Dohme (I.A.) Corp.
(Taiwan), Director at Ansun Biopharma, Inc., Vice President-Pharmaceutical Department at ArQule, Inc., and Chief Scientific Officer at Nu Skin Enterprises, Inc. from 1998 to 2000.
He was also a Partner at Delos Advisors Ltd. Dr. Chang received a doctorate degree from Brandeis University and an undergraduate degree from Fu Jen Catholic University.
Anciens postes connus de Michael Chang
| Sociétés | Poste | Fin |
|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Directeur Général | 05/05/2010 |
| NU SKIN ENTERPRISES, INC. | Directeur Technique/Scientifique/R&D | 01/01/2000 |
Ansun Biopharma, Inc.
 Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Private Equity Investor | - |
Merck Sharp & Dohme (I.A.) Corp. (Taiwan) | Corporate Officer/Principal | - |
Formation de Michael Chang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Nu Skin Enterprises, Inc.
 Nu Skin Enterprises, Inc. Household/Personal CareConsumer Non-Durables Develops and distributes personal care products and nutritional supplements | Consumer Non-Durables |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Pharmanex, Inc.
 Pharmanex, Inc. Food RetailRetail Trade Provides dietary supplements products | Retail Trade |
Merck Sharp & Dohme (I.A.) Corp. (Taiwan) | |
Fu Jen Catholic University
 Fu Jen Catholic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Finance |
Choisissez Zonebourse 
